Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
It is estimated that as much as $39.4 billion is spent annually on managing diabetes-related cardiovascular conditions (3, 116)
W., Tedjasaputra, V., Bailey, D
P.El-AgnafO.et al (2009)
Most patients begin to see weight loss after their dose has been increased one to two times, typically within a month
Steady progress
Targets both GLP-1 and GIP receptors Greater average weight loss than Semaglutide in clinical trials Reduces appetite and improves metabolic function Weekly self-injection FDA-approved for chronic weight management Tirzepatide at Bloom Aesthetics + Wellness $749 for a 10-week program
US$ 24.14
US$ 20.14
US$ 27.96
US$ 26.81
